48,466
edits
Difference between revisions of "TFE3-rearranged renal cell carcinoma"
Jump to navigation
Jump to search
TFE3-rearranged renal cell carcinoma (view source)
Revision as of 15:32, 27 January 2014
, 15:32, 27 January 2014→IHC
(→IHC) |
|||
| Line 74: | Line 74: | ||
*HMB-45 & Melan A -ve. | *HMB-45 & Melan A -ve. | ||
**Positive in ''epithelioid [[angiomyolipoma]]''. | **Positive in ''epithelioid [[angiomyolipoma]]''. | ||
Notes: | |||
*A longer list of less common markers is covered by Argani ''et al.''<ref>{{Cite journal | last1 = Argani | first1 = P. | last2 = Hicks | first2 = J. | last3 = De Marzo | first3 = AM. | last4 = Albadine | first4 = R. | last5 = Illei | first5 = PB. | last6 = Ladanyi | first6 = M. | last7 = Reuter | first7 = VE. | last8 = Netto | first8 = GJ. | title = Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers. | journal = Am J Surg Pathol | volume = 34 | issue = 9 | pages = 1295-303 | month = Sep | year = 2010 | doi = 10.1097/PAS.0b013e3181e8ce5b | PMID = 20679884 }}</ref> | |||
==Molecular== | ==Molecular== | ||